Articles tagged with Cancer Treatments
Rates of kidney failure caused by multiple myeloma have declined over the past decade, with a 20% reduction from 2001-2002 to 2009-2010. ESRD patients with multiple myeloma are also living longer and experiencing a decline in mortality within 3 years after initiating dialysis.
Scientists at The Wistar Institute have discovered how the SPOP gene suppresses tumor growth through induced senescence. When the gene is functioning properly, it acts as a tumor suppressor and induces senescence in cells.
Premature birth can be lifesaving with TPN, but it also causes liver damage. Dr. Ajay Jain is studying ways to prevent TPN-related complications in newborns.
New risk profiling approach aims to detect GI cancers, such as oesophageal adenocarcinoma, in early stages. The five-tier strategy involves lifestyle changes, non-invasive testing, and genetic analysis to tailor screening and prevention options for each individual.
A new analysis reveals that cancer diagnoses lead to significant declines in employment probability, hours worked, and income for American adults. Working-age men experience the most pronounced effects, with annual labor market earnings dropping by almost 40% within two years after diagnosis.
A new study reveals that cancer diagnoses lead to decreases in working hours and incomes, with effects primarily felt by male survivors. Total family income also declines, but recovers within four years after diagnosis.
Researchers at Stowers Institute have discovered a protein complex called SESAME that links glycolysis to chromatin modification, suggesting a potential target for detecting and treating cancers. The study's findings may also shed light on the relationship between cellular metabolism and gene expression in humans.
Researchers have discovered a new function of Histone H1 that helps summon repair proteins, leading to improved understanding of how cells protect and repair DNA damages. This discovery may eventually result in targeted treatments for diseases such as cancer and immune deficiency syndrome.
A multi-center trial found that therapy dogs can reduce anxiety levels and improve heart rate stability in children with cancer, as well as their parents. The study provides the first solid data on the psychosocial benefits of animal-assisted interventions for pediatric cancer patients.
Biotech expert Mitchell Finer shares his experiences and strategies for achieving commercial success, including the importance of clinical data and access to capital. He also discusses the growth of companies like bluebird bio and Cell Genesys, and the potential for gene therapy to revolutionize treatment options.
Researchers have created a new material combining nanodiamonds, gutta-percha, and amoxicillin to strengthen root canal fillings and kill bacteria. The material shows promise in preventing re-infections and improving current therapies.
New study reveals that histone deacetylase 6 inhibition improves the ability of oncolytic herpes simplex virus type 1 to kill glioma cells. HDAC inhibitors increase viral trafficking to the nucleus, leading to increased replication and tumor cell death.
Researchers identified key metabolic changes that occur in patients with myeloma and those at risk of developing the disease. The findings suggest a potential drug target to prevent progression from benign MGUS to cancerous myeloma.
Researchers have discovered a link between Diamond-Blackfan anaemia and increased cancer susceptibility, using a new animal model that recapitulates key characteristics of the disease. The study found that patients with DBA are predisposed to lymphomas and solid tumours due to mutations in the RPL11 protein.
Researchers have discovered a new gene, snoRNA42, linked to an increased risk of bowel cancer recurrence and shortened survival. This gene may serve as a reliable biomarker for selecting high-risk patients who can benefit from personalized treatments.
Patients with lower household income below $50,000 had 32% lower odds of participating in clinical trials compared to higher income patients. The study found that trial participation decreased as annual household income decreased from $50,000 or higher to between $20,000 and $49,999 and to less than $20,000.
A study found that a specific gene signature called MG5 can divide intermediate-risk rhabdomyosarcoma patients into two separate risk groups. Those with high MG5 scores had poorer survival outcomes and were seven times more likely to die of the disease.
Primary care providers should screen men aged 45 and older with a digital rectal exam (DRE) and prostate-specific antigen (PSA) test. If the patient is asymptomatic, a 5-year screening interval may be considered.
A recent study by researchers at King's College London found that general practices using the urgent referral pathway (two-week wait system) have lower cancer mortality rates compared to those that rarely use this pathway. Increasing its use could improve patient survival, especially for patients from low-referring practices.
A study by Cancer Research UK and King's College London found that cancers diagnosed at a later stage have higher mortality rates, with death rates increasing by seven per cent in practices using the two-week referral route least often. Increasing GP cancer awareness could help reduce deaths.
African-American women are more likely to develop aggressive breast cancer subtypes and receive substandard care compared to non-Hispanic white women. Minority women also experience disparities in treatment across all breast cancer stages, with significant differences in diagnosis timing and treatment approaches.
A new pneumatic compression device has been shown to significantly reduce cellulitis episodes in patients with lymphedema, resulting in an 80% decrease. The device also leads to a 37% reduction in lymphedema-related healthcare costs. This study highlights the potential benefits of advanced devices in managing chronic conditions.
Researchers found that patients with advanced cancer are willing to pay more for aspects of a good end-of-life experience compared to healthy older adults. Both groups highly value high-quality healthcare experiences, including being treated with respect and receiving coordinated care. The study suggests that health reform efforts shou...
Disparities in retinoblastoma outcomes exist among children of different ethnicities and socioeconomic statuses, with Hispanic children having a higher percentage of extraocular disease and being more likely to undergo enucleation. Low socioeconomic status is associated with greater risks for advanced disease and poorer ocular outcomes.
Cancer cases worldwide are projected to reach almost 22 million by 2030, with low- and middle-income countries facing unsustainable economic burdens. Effective cancer prevention campaigns have shown promising results in Taiwan, Rwanda, and Brazil, highlighting the importance of rapid implementation of control programs.
The Lancet Oncology Commission highlights the vital role of primary care doctors in preventing, detecting, survivorship, and palliative care. Effective integration between primary and specialist care is crucial to meet the growing demand for cancer care.
The National Institute on Aging has awarded a grant of $3.567M to study mechanisms of Alzheimer's disease, with a focus on immune system cells that cause synapse damage.
Researchers at Harvard University have discovered a molecule that can halt the growth of cancerous AML cells without harming healthy cells. The molecule, cortistatin A, works by inhibiting two specific kinases that play a key role in the growth of AML cells.
Researchers identified distinct characteristics among non-smoking patients with NSCLC, such as lower chronic obstructive pulmonary disease and heart disease rates. Non-smokers also exhibited longer survival periods after diagnosis compared to smokers.
Patients with recurrent lung cancer who undergo a CT-based follow-up program after surgery experience significantly improved post-surgery survival rates. The study analyzed 391 patients and found that the number of patients alive four years after surgery increased from 54% to an estimated 68%.
Researchers identified a mutated POT1 gene in families with multiple tumors, including cardiac angiosarcoma. The finding opens up the possibility of early diagnosis and treatment for family members.
Researchers have identified a key role for the WWOX gene in suppressing cancer development. Lower levels of WWOX are associated with more aggressive and treatment-resistant cancers. The study suggests that targeting the enzyme activity of WWOX could influence cancer cell properties.
A new UCLA study reveals that Alzheimer's disease consists of three distinct subtypes, each requiring targeted research and potential new treatments. The cortical subtype appears to be fundamentally different from the other two, suggesting different causes and optimal treatment approaches.
Researchers discovered that antidepressant amitriptyline increases FGF2 mRNA expression in astrocytes through RTK activation. This signaling cascade could guide the development of novel antidepressants with new mechanisms. The study expands on previous findings, identifying EGR1 as a necessary protein for FGF2 expression.
Researchers at Mayo Clinic's Florida campus have been awarded a $13.3 million grant to conduct a national, phase II clinical trial testing the ability of a folate receptor alpha vaccine to prevent recurrence of triple-negative breast cancer following initial treatment. The vaccine was designed by Dr. Keith Knutson and exploits the need...
Scientists have identified a FOXC1 gene that causes more aggressive cancer in AML patients. When switched on in blood cell tissue, it stunts the development of blood cells and stops them maturing into normal specialized blood cells, leading to faster cancer growth.
Researchers at Nanjing University have discovered new epigenetic markers for colorectal cancer, which may offer a new approach for treatment. The study found that heterochromatin protein HP1γ was critical for CRC cell proliferation and could be specially regulated by miR-30a.
Researchers discovered that Tie1 controls angiogenesis and vascular remodeling by differentially regulating Tie2 in tip and stalk cells, making it a promising therapeutic target for cancer treatment and eye diseases.
Research suggests a treatment that boosts the immune system could improve liver failure treatment outcomes. The therapy uses an immune-boosting molecule called CSF-1 to trigger natural defence mechanisms in the liver.
The International Association for the Study of Lung Cancer has released new data for the TNM classification of lung cancer, which will inform the Eighth Edition of the staging manual. The new database includes 94,708 patients diagnosed worldwide from 1999-2010 and analyzes tumor size, lymph node involvement, and metastatic status.
A new model for preventing and treating obesity in the United States has been proposed, integrating healthcare with community resources. The model centers on individual patients and family engagement, restructuring clinical services to address stigmatization and promoting behavioral changes.
A new study has found that children with coeliac disease react to the same key toxic proteins in gluten as adults, suggesting a potential breakthrough in treatments. The research supports the use of existing treatments and diagnostic tests for adults with coeliac disease for children.
The Mayo Clinic Cancer Center has been awarded a Specialized Program of Research Excellence (SPORE) grant to study the genetic basis of multiple myeloma and develop novel therapies.
Researchers at Johns Hopkins Medicine analyzed survival statistics of 1,298 men with low-risk prostate tumors and found that only two died of prostate cancer after 15 years, while three developed metastatic disease. This suggests that carefully selected patients in active surveillance programs are unlikely to be harmed by their disease.
A 10% increase in wages leads to a 5% drop in smoking rates among male workers with low education levels. Increasing the minimum wage could improve quitting rates for smokers and has significant health benefits.
A study by Helmholtz Munich researchers identified a key role of the protein BMP7 in promoting cell division and migration in pheochromocytoma cells. Targeting this signaling pathway with specific substances may lead to an increase in apoptosis, providing a new approach for treatment.
Daily changes in nuclear positioning of circadian genes regulate their activity with a 24-hour period. Researchers identified two proteins PARP1 and CTCF that bring genes to the periphery, promoting silent state.
The discovery reveals protein structural changes that could inform treatments for inflammatory conditions such as heart disease and colon cancer. The researchers found that two proteins, Tollip and Tom1, work together to regulate the turnover of cell-surface receptor proteins that trigger inflammation.
The study reveals that the mutation disrupts normal cell function by interfering with RNA and protein movement into and out of the nucleus. This leads to neuronal deterioration and death in the brain and spinal cord, causing loss of voluntary muscle movement, paralysis, and respiratory failure.
A study by German Cancer Research Center discovered that citric acid from lemon juice can alter the morphology of norovirus particles, reducing their infectivity. The researchers found that citrate binds to specific proteins on the virus, preventing it from attaching to host cells.
A nine-gene molecular prognostic index (MPI) provides accurate survival stratification for early-stage non-small cell lung cancer (NSCLC) patients. The MPI combines gene expression profiles with clinical data from a large database, enabling robust and clinically applicable predictions.
Researchers found that powdered cranberry combats colon cancer in mice by reducing tumor size and number. The study suggests that individual components of the fruit could lead to a better understanding of its anti-cancer potential, potentially leading to more effective treatments for colon cancer.
Rice University bioengineers have developed a technique called progeny clustering that clarifies big data clusters, enabling doctors to design personalized treatments. The algorithm increases the size of data sets and reveals distinct patterns, allowing for more accurate cluster grouping.
A recent study published in The Annals of Thoracic Surgery found that patients with suspected lung cancer often wait too long to receive treatment and skip vital diagnostic steps. Only 1 in 10 patients had the recommended combination of three staging tests before surgery, highlighting the need for improved quality care.
A $1.5 million gift will support research in spinal muscular atrophy with respiratory distress (SMARD), a rare condition affecting fewer than 70 reported cases worldwide. The funding will enable the development of effective treatments and therapies for children impacted by this devastating disease.
Researchers discovered that patients with detectable HPV16 DNA in their saliva after cancer treatment are more likely to develop cancer recurrence. The finding could lead to earlier detection and better prognosis for these patients, enabling them to receive timely treatment options.
A study of over 70,000 cancer patients found that those referred late by their GP were more likely to be dissatisfied with their care. Patients who experienced referral delays reported negative experiences across various aspects of their care, including diagnosis and treatment.
The study found that persistent HPV16 DNA detection after treatment was associated with worse disease-free survival and overall survival. This could be a useful tool for long-term tumor surveillance, potentially reducing the need for costly imaging and intensifying visits.
Researchers have identified five distinct types of prostate cancer with unique genetic fingerprints, which could help doctors predict the aggressiveness of tumors and choose the best course of treatment. This breakthrough discovery has important implications for how prostate cancer is diagnosed and treated in the future.
Researchers discovered a small RNA molecule called miR-148a plays a role in lung cancer resistance to TRAIL, and inhibiting NF-κB makes it more effective. This study suggests a way to overcome resistance and develop new treatments for lung cancer.